D5dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Activation of D 1-like receptors (D 1 and/or D 5) induces antioxidant responses; however, the mechanism(s) involved in their antioxidant actions are not known. We hypothesized that stimulation of the D 5 receptor inhibits NADPH oxidase activity, and thus the production of reactive oxygen species (ROS). We investigated this issue in D 5 receptor-deficient (D 5−/−) and wild-type (D 5+/+) mice. NADPH oxidase protein expression (gp91 phox, p47 phox, and Nox 4) and activity in kidney and brain, as well as plasma thiobarbituric acid-reactive substances (TBARS) were higher in D 5−/− than in D 5+/+ mice. Furthermore, apocynin, an NADPH oxidase inhibitor, normalized blood pressure, renal NADPH oxidase activity, and plasma TBARS in D 5−/− mice. In HEK-293 cells that heterologously expressed human D 5 receptor, its agonist fenoldopam decreased NADPH oxidase activity, expression of one of its subunits (gp91 phox), and ROS production. The inhibitory effect of the D 5 receptor activation on NADPH oxidase activity was independent of cAMP/PKA but was partially dependent on phospholipase D2. The ability of D 5 receptor stimulation to decrease ROS production may explain, in part, the antihypertensive action of D 5 receptor activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pollock, J. D., Williams, D. A., Gifford, M. A. C., Li, L. L., Du, X., Fisherman, J., Orkin, S. H., Doerschuk, C. M., & Dinauer, M. C. (1995) · Nature Genetics · doi:10.1038/ng0295-202 · Cited by 921 · cited 1×
“The difference in size is due to the lower level of glycosylation present in murine gp91, which is due to the absence of glycosylation sites (39).”
BackgroundThe vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases
Cai, H., Griendling, K. K., & Harrison, D. G. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00233-5 · Cited by 687
Touyz, R. M., Chen, X., Tabet, F., Yao, G., He, G., Quinn, M. T., Pagano, P. J., & Schiffrin, E. L. (2002) · Circulation Research · doi:10.1161/01.res.0000020404.01971.2f · Cited by 590 · cited 4×
“A major source of O2 in vascular tissues and kidney is NADPH oxidase, an enzymatic complex that consists of six subunits: membrane subunits p22phox and gp91phox, cytosolic components p40phox, p47phox, and p67phox, and a low-molecularweight G protein Rac1 or Rac2 (4, 18, 41, 49, 51).”
BackgroundInfluentialSelf-citationQuinn, M. T., & Gauss, K. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0404216 · Cited by 480
Self-citation
Cited by
Nox enzymes, ROS, and chronic disease: An example of antagonistic pleiotropy
Lambeth, J. D. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.027 · Cited by 679
Chemistry and Antihypertensive Effects of Tempol and Other Nitroxides
Wilcox, C. S., & Pearlman, A. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000240 · Cited by 377
Dopamine, Immunity, and Disease
Channer, B., Matt, S. M., Nickoloff-Bybel, E. A., Pappa, V., Agarwal, Y., Wickman, J., & Gaskill, P. J. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000618 · Cited by 308
Villar, V. A. M., Jones, J. E., Armando, I., Asico, L. D., Escano, C. S., Lee, H., Wang, X., Yang, Y., Pascua-Crusan, A. M., Palmes-Saloma, C. P., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.428458 · Cited by 33
Self-citation
Metadata
- Authors
- Yang, Z., Asico, L. D., Yu, P., Wang, Z., Jones, J. E., Escano, C. S., Wang, X., Quinn, M. T., Sibley, D. R., Romero, G. G., Felder, R. A., & Jose, P. A.
- Venue
- American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Publisher
- American Physiological Society
- Published
- 2006-01
- Volume
- 290
- Issue
- 1
- Pages
- R96-R104
- ISSN
- 0363-6119 (ISSN-L)
- 1522-1490
- OpenAlex
- W2116109401
- Cited by
- 100
- References
- 4
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.